Respiratory Syncytial Virus Immunoprophylaxis: Issues in Short-term and Longer-term Impact
- PMID: 31239288
- DOI: 10.1542/peds.2019-0153
Respiratory Syncytial Virus Immunoprophylaxis: Issues in Short-term and Longer-term Impact
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: Dr. Krilov has consulted for Pfizer and has received clinical trial support from AstraZeneca (MedImmune) and Regeneron. Dr. Krilov is site principal investigator for an unrelated multi-centered pediatric vaccine trial sponsored by Sanofi Pasteur with all monies paid to his institution.
Comment on
-
Palivizumab and Long-term Outcomes in Cystic Fibrosis.Pediatrics. 2019 Jul;144(1):e20183495. doi: 10.1542/peds.2018-3495. Pediatrics. 2019. PMID: 31239289
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
